No Prescription |
 |
 | ||
|
Cataflam Voltaren |
|
| ||
No Prescription » Prescription Drugs 3 » Cataflam Voltaren Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Nonsteroidal anti-inflammatory drugs (also called NSAIDs) are used to relieve some symptoms caused by arthritis (rheumatism) such as inflammation swelling stiffness and joint pain. However this medicine does not cure arthritis and will help you only as long as you continue to take it. Some of these medicines are also used to relieve other kinds of pain or to treat other painful conditions such as: gout attacks; bursitis; tendinitis; sprains strains or other injuries; or menstrual cramps. Voltaren and Cataflam are nonsteroidal anti-inflammatory drugs used to relieve the inflammation swelling stiffness and joint pain associated with rheumatoid arthritis osteoarthritis (the most common form of arthritis) and ankylosing spondylitis (arthritis and stiffness of the spine). Voltaren-XR the extended-release form of Voltaren is used only for long-term treatment. Cataflam is also prescribed for immediate relief of pain and menstrual discomfort. Buy Cataflam Voltaren and other Prescription Drugs 3 products online at Medstore. 3869
About Cataflam Voltaren: Product Type: Prescription Drugs 3 Cataflam ( Voltaren Voltaren SR Generic Diclofenac ) Cataflam (Voltaren Voltaren SR Generic Diclofenac) Voltaren Voltaren SR Generic Diclofenac 50mg 60 ( 3 x 20 ) Tabs Voltaren Voltaren SR Generic Diclofenac Cataflam
View more Prescription Drugs 3 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
